 |
| PreciPoint's co-founders Dominik Gerber und Nicolas Weiss, who are leading the company's efforts to commercialize digital pathology solutions for intra-operative use in cancer surgeries. It is hoped that the approach will lead to much faster and more effective determination of tumor margins during surgery - ensuring that as much cancerous tissue as possible is removed by surgeons. Photo: PreciPoint. |
| © 2024 SPIE Europe |
|
